ArticleCellular oncology (Dordrecht, Netherlands)2021

MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer.

Sung Hwan Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.